Submission Details
| 510(k) Number | K251193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 17, 2025 |
| Decision Date | June 12, 2025 |
| Days to Decision | 56 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K251193 is an FDA 510(k) clearance for the Grafton? DBM; Grafton Plus? DBM Paste; Magnifuse? Bone Graft, a Filler, Bone Void, Calcium Compound (Class II — Special Controls, product code MQV), submitted by Medtronic Sofamor Danek, Inc. (Memphis, US). The FDA issued a Cleared decision on June 12, 2025, 56 days after receiving the submission on April 17, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3045.
| 510(k) Number | K251193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 17, 2025 |
| Decision Date | June 12, 2025 |
| Days to Decision | 56 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MQV — Filler, Bone Void, Calcium Compound |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3045 |